Company / Free Cash Flow
Valion Bio, Inc. Free Cash Flow History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$8.6M
FY2024
5-year range
-$8.9M / -$5.6M
FY2022-FY2024
Trend
+3.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$6M to -$9M over the past 2 years.
Based on SEC 10-K filings.
-$9M in FY2024.
Declined from -$6M to -$9M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, free cash flow increased 3.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$8.6M | +3.4% |
| FY2023 | -$8.9M | -58.8% |
| FY2022 | -$5.6M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026